
newGenia, a business segment of Chrom 1 AB, specializes in developing tools and services that enable faster, cheaper, and secure DNA analysis through a modular approach. Their platform leverages AI and multi-omics for comprehensive data analysis, integrating clinical health records and extensive literature to provide evidence at all stages. The company offers a cloud-onsite hybrid platform designed for accessible, high-speed bioinformatics tailored for clinicians, making complex genomic data interpretation more accessible and navigable. Their key services include multi-omics and AI-based interpretation and clinical bioinformatics for clinicians, positioning newGenia as a significant player in the clinical bioinformatics and genomics market.

newGenia, a business segment of Chrom 1 AB, specializes in developing tools and services that enable faster, cheaper, and secure DNA analysis through a modular approach. Their platform leverages AI and multi-omics for comprehensive data analysis, integrating clinical health records and extensive literature to provide evidence at all stages. The company offers a cloud-onsite hybrid platform designed for accessible, high-speed bioinformatics tailored for clinicians, making complex genomic data interpretation more accessible and navigable. Their key services include multi-omics and AI-based interpretation and clinical bioinformatics for clinicians, positioning newGenia as a significant player in the clinical bioinformatics and genomics market.